SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on January 22, 2018, reporting events occurring on January 16, 2018. The registrant is incorporated in California and operates in the medical products sector. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as "Second Sight Medical Products, Inc."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the departure of an executive officer:
- Gregoire Cosendai, Vice President of Clinical Affairs, ceased to be an employee of the Company and its subsidiary, Second Sight Medical Products (Switzerland) Sarl, effective January 16, 2018.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the executive departure.
Key Facts for Investor Verification
- Confirm the exact date of departure for Gregoire Cosendai (January 16, 2018).
- Verify if a successor has been appointed for the Vice President of Clinical Affairs role.
- Check subsequent filings for any impact of this departure on clinical trials or regulatory submissions.
- Clarify the discrepancy between the requested company name (Vivani Medical) and the filing registrant (Second Sight Medical Products).